Drug recalls

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made…

Ajanta Pharma USA Inc · Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.…

Class IIIOngoingD-0836-2026
Status
Ongoing
City
Bridgewater
State
NJ
Country
United States
Classification
Class III
Product type
Drugs
Event ID
99733
Recalling firm
Ajanta Pharma USA Inc
Address 1
400 Crossing Blvd Ste 102
Postal code
08807-2863
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
Nationwide within the U.S
Recall number
D-0836-2026
Product quantity
403,200 tablets
Recall initiation date
20260825
Center classification date
20260908
Report date
20260916
Code info
Lot #: DJ23254, Exp. Date 11/30/2026; DJ10205, Exp. Date 04/30/2027.
Product description

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01.

Reason for recall

Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

Harmonized identifiers (openFDA)
Application number
ANDA217410
Brand name
FLUPHENAZINE HYDROCHLORIDE
Generic name
FLUPHENAZINE HYDROCHLORIDE
Manufacturer name
Ajanta Pharma USA Inc.
Product NDC
27241-252, 27241-255, 27241-254, 27241-253
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
FLUPHENAZINE HYDROCHLORIDE
RxCUI
859841, 860918, 865117, 865123
SPL ID
0069bda4-a743-4edd-a15f-a53cba1a2bff
SPL set ID
47695e20-9c0b-4a6b-ab1a-1dfaa75e96d8
Package NDC
27241-255-01, 27241-254-01, 27241-253-01, 27241-252-01
Is original packager
true
Upc
0327241255014, 0327241252013, 0327241253010, 0327241254017
UNII
ZOU145W1XL
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.